APO Research
Talk to an analyst

APO RESEARCH · REPORT

Nimodipine Injection

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Nimodipine Injection Market Outlook and Growth Opportunities 2026

29 December 2025196 pages

Choose your research edition.

Industry ResearchNimodipine Injection Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal Nimodipine Injection Industry Growth and Trends Forecast to 203298 pages · $3,450 USDMarket StructureGlobal Nimodipine Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032184 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Nimodipine Injection Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Nimodipine Injection Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Nimodipine Injection market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Nimodipine Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Nimodipine Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Nimodipine Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Nimodipine Injection market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Nimodipine Injection market include Huiyu Pharmaceutical, Bayer, Lexicare Pharma, Cisen Pharmaceutical and Actiza Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Nimodipine Injection market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Nimodipine Injection and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Nimodipine Injection sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Nimodipine Injection market size, projected growth trends, production technologies, key applications, and end-use industries.

Nimodipine Injection Segment by Company

Huiyu Pharmaceutical

Bayer

Lexicare Pharma

Cisen Pharmaceutical

Actiza Pharmaceutical

Nimodipine Injection Segment by Type

50ml:10mg

100ml:20mg

Nimodipine Injection Segment by Application

Hospital

Clinic

Nimodipine Injection Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Nimodipine Injection status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Nimodipine Injection market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Nimodipine Injection significant trends, drivers, influence factors in global and regions.

6. To analyze Nimodipine Injection competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nimodipine Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Nimodipine Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nimodipine Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Nimodipine Injection market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Nimodipine Injection industry.

Chapter 3: Detailed analysis of Nimodipine Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Nimodipine Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Nimodipine Injection in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Nimodipine Injection Industry Trends Table 2. Nimodipine Injection Industry Drivers Table 3. Nimodipine Injection Industry Opportunities and Challenges Table 4. Nimodipine Injection Industry Restraints Table 5. Global Nimodipine Injection Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Nimodipine Injection Revenue Share by Company (2021-2026) Table 7. Global Nimodipine Injection Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Nimodipine Injection Sales Volume Share by Company (2021-2026) Table 9. Global Nimodipine Injection Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Nimodipine Injection Company Ranking, (2024-2026) & (USD Million) Table 11. Global Nimodipine Injection Key Company Manufacturing Base & Headquarters Table 12. Global Nimodipine Injection Company, Product Type & Application Table 13. Global Nimodipine Injection Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Nimodipine Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of 50ml:10mg Table 18. Significant Companies of 100ml:20mg Table 19. Global Nimodipine Injection Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Nimodipine Injection Sales Volume by Type (2021-2026) & (K Units) Table 21. Global Nimodipine Injection Sales Volume by Type (2027-2032) & (K Units) Table 22. Global Nimodipine Injection Sales Volume Share by Type (2021-2026) Table 23. Global Nimodipine Injection Sales Volume Share by Type (2027-2032) Table 24. Global Nimodipine Injection Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Nimodipine Injection Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Nimodipine Injection Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Nimodipine Injection Sales Value Share by Type (2021-2026) Table 28. Global Nimodipine Injection Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Hospital Table 30. Significant Companies of Clinic Table 31. Global Nimodipine Injection Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 32. Global Nimodipine Injection Sales Volume by Application (2021-2026) & (K Units) Table 33. Global Nimodipine Injection Sales Volume by Application (2027-2032) & (K Units) Table 34. Global Nimodipine Injection Sales Volume Share by Application (2021-2026) Table 35. Global Nimodipine Injection Sales Volume Share by Application (2027-2032) Table 36. Global Nimodipine Injection Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Nimodipine Injection Sales Value by Application (2021-2026) & (US$ Million) Table 38. Global Nimodipine Injection Sales Value by Application (2027-2032) & (US$ Million) Table 39. Global Nimodipine Injection Sales Value Share by Application (2021-2026) Table 40. Global Nimodipine Injection Sales Value Share by Application (2027-2032) Table 41. Global Nimodipine Injection Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 42. Global Nimodipine Injection Sales by Region (2021-2026) & (K Units) Table 43. Global Nimodipine Injection Sales Market Share by Region (2021-2026) Table 44. Global Nimodipine Injection Sales by Region (2027-2032) & (K Units) Table 45. Global Nimodipine Injection Sales Market Share by Region (2027-2032) Table 46. Global Nimodipine Injection Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Nimodipine Injection Sales Value by Region (2021-2026) & (US$ Million) Table 48. Global Nimodipine Injection Sales Value Share by Region (2021-2026) Table 49. Global Nimodipine Injection Sales Value by Region (2027-2032) & (US$ Million) Table 50. Global Nimodipine Injection Sales Value Share by Region (2027-2032) Table 51. Global Nimodipine Injection Market Average Price (US$/Unit) by Region (2021-2026) Table 52. Global Nimodipine Injection Market Average Price (US$/Unit) by Region (2027-2032) Table 53. Global Nimodipine Injection Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 54. Global Nimodipine Injection Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 55. Global Nimodipine Injection Sales by Country (2021-2026) & (K Units) Table 56. Global Nimodipine Injection Sales Market Share by Country (2021-2026) Table 57. Global Nimodipine Injection Sales by Country (2027-2032) & (K Units) Table 58. Global Nimodipine Injection Sales Market Share by Country (2027-2032) Table 59. Global Nimodipine Injection Sales Value by Country (2021-2026) & (US$ Million) Table 60. Global Nimodipine Injection Sales Value Market Share by Country (2021-2026) Table 61. Global Nimodipine Injection Sales Value by Country (2027-2032) & (US$ Million) Table 62. Global Nimodipine Injection Sales Value Market Share by Country (2027-2032) Table 63. Huiyu Pharmaceutical Company Information Table 64. Huiyu Pharmaceutical Business Overview Table 65. Huiyu Pharmaceutical Nimodipine Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Huiyu Pharmaceutical Nimodipine Injection Product Portfolio Table 67. Huiyu Pharmaceutical Recent Development Table 68. Bayer Company Information Table 69. Bayer Business Overview Table 70. Bayer Nimodipine Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Bayer Nimodipine Injection Product Portfolio Table 72. Bayer Recent Development Table 73. Lexicare Pharma Company Information Table 74. Lexicare Pharma Business Overview Table 75. Lexicare Pharma Nimodipine Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Lexicare Pharma Nimodipine Injection Product Portfolio Table 77. Lexicare Pharma Recent Development Table 78. Cisen Pharmaceutical Company Information Table 79. Cisen Pharmaceutical Business Overview Table 80. Cisen Pharmaceutical Nimodipine Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Cisen Pharmaceutical Nimodipine Injection Product Portfolio Table 82. Cisen Pharmaceutical Recent Development Table 83. Actiza Pharmaceutical Company Information Table 84. Actiza Pharmaceutical Business Overview Table 85. Actiza Pharmaceutical Nimodipine Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Actiza Pharmaceutical Nimodipine Injection Product Portfolio Table 87. Actiza Pharmaceutical Recent Development Table 88. Key Raw Materials Table 89. Raw Materials Key Suppliers Table 90. Nimodipine Injection Distributors List Table 91. Nimodipine Injection Customers List Table 92. Research Programs/Design for This Report Table 93. Authors List of This Report Table 94. Secondary Sources Table 95. Primary Sources List of Figures Figure 1. Nimodipine Injection Product Image Figure 2. Global Nimodipine Injection Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Nimodipine Injection Sales Value (2021-2032) & (US$ Million) Figure 4. Global Nimodipine Injection Sales (2021-2032) & (K Units) Figure 5. Global Nimodipine Injection Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Nimodipine Injection Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. 50ml:10mg Image Figure 10. 100ml:20mg Image Figure 11. Global Nimodipine Injection Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Nimodipine Injection Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Nimodipine Injection Sales Volume Share by Type (2021-2032) Figure 14. Global Nimodipine Injection Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Nimodipine Injection Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Nimodipine Injection Sales Value Share by Type (2021-2032) Figure 17. Hospital Image Figure 18. Clinic Image Figure 19. Global Nimodipine Injection Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 20. Global Nimodipine Injection Sales Volume Share 2021 VS 2025 VS 2032 Figure 21. Global Nimodipine Injection Sales Volume Share by Application (2021-2032) Figure 22. Global Nimodipine Injection Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Nimodipine Injection Sales Value Share 2021 VS 2025 VS 2032 Figure 24. Global Nimodipine Injection Sales Value Share by Application (2021-2032) Figure 25. Global Nimodipine Injection Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 26. Global Nimodipine Injection Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 27. Global Nimodipine Injection Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 28. Global Nimodipine Injection Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 29. North America Nimodipine Injection Sales Value (2021-2032) & (US$ Million) Figure 30. North America Nimodipine Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Europe Nimodipine Injection Sales Value (2021-2032) & (US$ Million) Figure 32. Europe Nimodipine Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Asia-Pacific Nimodipine Injection Sales Value (2021-2032) & (US$ Million) Figure 34. Asia-Pacific Nimodipine Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 35. South America Nimodipine Injection Sales Value (2021-2032) & (US$ Million) Figure 36. South America Nimodipine Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Middle East & Africa Nimodipine Injection Sales Value (2021-2032) & (US$ Million) Figure 38. Middle East & Africa Nimodipine Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 39. USA Nimodipine Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. USA Nimodipine Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. USA Nimodipine Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Canada Nimodipine Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Canada Nimodipine Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Canada Nimodipine Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Mexico Nimodipine Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Mexico Nimodipine Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Mexico Nimodipine Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Germany Nimodipine Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Germany Nimodipine Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Germany Nimodipine Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. France Nimodipine Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. France Nimodipine Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. France Nimodipine Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. U.K. Nimodipine Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. U.K. Nimodipine Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. U.K. Nimodipine Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Italy Nimodipine Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Italy Nimodipine Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Italy Nimodipine Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Spain Nimodipine Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Spain Nimodipine Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Spain Nimodipine Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Russia Nimodipine Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Russia Nimodipine Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Russia Nimodipine Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Netherlands Nimodipine Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Netherlands Nimodipine Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Netherlands Nimodipine Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Nordic Countries Nimodipine Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Nordic Countries Nimodipine Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Nordic Countries Nimodipine Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. China Nimodipine Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. China Nimodipine Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. China Nimodipine Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Japan Nimodipine Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Japan Nimodipine Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Japan Nimodipine Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. South Korea Nimodipine Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. South Korea Nimodipine Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. South Korea Nimodipine Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. India Nimodipine Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. India Nimodipine Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. India Nimodipine Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Australia Nimodipine Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Australia Nimodipine Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Australia Nimodipine Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Southeast Asia Nimodipine Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Southeast Asia Nimodipine Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Southeast Asia Nimodipine Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Brazil Nimodipine Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Brazil Nimodipine Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Brazil Nimodipine Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Argentina Nimodipine Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Argentina Nimodipine Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Argentina Nimodipine Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Chile Nimodipine Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Chile Nimodipine Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Chile Nimodipine Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Colombia Nimodipine Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Colombia Nimodipine Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Colombia Nimodipine Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Peru Nimodipine Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Peru Nimodipine Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Peru Nimodipine Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Saudi Arabia Nimodipine Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Saudi Arabia Nimodipine Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Nimodipine Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Israel Nimodipine Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Israel Arabia Nimodipine Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Israel Arabia Nimodipine Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. UAE Nimodipine Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. UAE Nimodipine Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. UAE Nimodipine Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Turkey Nimodipine Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Turkey Nimodipine Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Turkey Nimodipine Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Iran Nimodipine Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Iran Nimodipine Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Iran Nimodipine Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Egypt Nimodipine Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Egypt Nimodipine Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Egypt Nimodipine Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Nimodipine Injection Value Chain Figure 124. Manufacturing Cost Structure Figure 125. Nimodipine Injection Sales Mode & Process Figure 126. Direct Comparison with Distribution Share Figure 127. Distributors Profiles Figure 128. Years Considered Figure 129. Research Process Figure 130. Key Executives Interviewed

Scope & coverage.

Types
  • 50ml:10mg
  • 100ml:20mg
Applications
  • Hospital
  • Clinic
Companies covered
  • Huiyu Pharmaceutical
  • Bayer
  • Lexicare Pharma
  • Cisen Pharmaceutical
  • Actiza Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Nimodipine Injection Sales Value (2021-2032)
  4. 1.2.2 Global Nimodipine Injection Sales Volume (2021-2032)
  5. 1.2.3 Global Nimodipine Injection Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Nimodipine Injection Market Dynamics
  1. 2.1 Nimodipine Injection Industry Trends
  2. 2.2 Nimodipine Injection Industry Drivers
  3. 2.3 Nimodipine Injection Industry Opportunities and Challenges
  4. 2.4 Nimodipine Injection Industry Restraints
3 Nimodipine Injection Market by Company
  1. 3.1 Global Nimodipine Injection Company Revenue Ranking in 2025
  2. 3.2 Global Nimodipine Injection Revenue by Company (2021-2026)
  3. 3.3 Global Nimodipine Injection Sales Volume by Company (2021-2026)
  4. 3.4 Global Nimodipine Injection Average Price by Company (2021-2026)
  5. 3.5 Global Nimodipine Injection Company Ranking (2024-2026)
  6. 3.6 Global Nimodipine Injection Company Manufacturing Base and Headquarters
  7. 3.7 Global Nimodipine Injection Company Product Type and Application
  8. 3.8 Global Nimodipine Injection Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Nimodipine Injection Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Nimodipine Injection Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Nimodipine Injection Market by Type
  1. 4.1 Nimodipine Injection Type Introduction
  2. 4.1.1 50ml:10mg
  3. 4.1.2 100ml:20mg
  4. 4.2 Global Nimodipine Injection Sales Volume by Type
  5. 4.2.1 Global Nimodipine Injection Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Nimodipine Injection Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Nimodipine Injection Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Nimodipine Injection Sales Value by Type
  9. 4.3.1 Global Nimodipine Injection Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Nimodipine Injection Sales Value by Type (2021-2032)
  11. 4.3.3 Global Nimodipine Injection Sales Value Share by Type (2021-2032)
5 Nimodipine Injection Market by Application
  1. 5.1 Nimodipine Injection Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.2 Global Nimodipine Injection Sales Volume by Application
  5. 5.2.1 Global Nimodipine Injection Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Nimodipine Injection Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Nimodipine Injection Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Nimodipine Injection Sales Value by Application
  9. 5.3.1 Global Nimodipine Injection Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Nimodipine Injection Sales Value by Application (2021-2032)
  11. 5.3.3 Global Nimodipine Injection Sales Value Share by Application (2021-2032)
6 Nimodipine Injection Regional Sales and Value Analysis
  1. 6.1 Global Nimodipine Injection Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Nimodipine Injection Sales by Region (2021-2032)
  3. 6.2.1 Global Nimodipine Injection Sales by Region: 2021-2026
  4. 6.2.2 Global Nimodipine Injection Sales by Region (2027-2032)
  5. 6.3 Global Nimodipine Injection Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Nimodipine Injection Sales Value by Region (2021-2032)
  7. 6.4.1 Global Nimodipine Injection Sales Value by Region: 2021-2026
  8. 6.4.2 Global Nimodipine Injection Sales Value by Region (2027-2032)
  9. 6.5 Global Nimodipine Injection Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Nimodipine Injection Sales Value (2021-2032)
  12. 6.6.2 North America Nimodipine Injection Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Nimodipine Injection Sales Value (2021-2032)
  15. 6.7.2 Europe Nimodipine Injection Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Nimodipine Injection Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Nimodipine Injection Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Nimodipine Injection Sales Value (2021-2032)
  21. 6.9.2 South America Nimodipine Injection Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Nimodipine Injection Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Nimodipine Injection Sales Value Share by Country, 2025 VS 2032
7 Nimodipine Injection Country-level Sales and Value Analysis
  1. 7.1 Global Nimodipine Injection Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Nimodipine Injection Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Nimodipine Injection Sales by Country (2021-2032)
  4. 7.3.1 Global Nimodipine Injection Sales by Country (2021-2026)
  5. 7.3.2 Global Nimodipine Injection Sales by Country (2027-2032)
  6. 7.4 Global Nimodipine Injection Sales Value by Country (2021-2032)
  7. 7.4.1 Global Nimodipine Injection Sales Value by Country (2021-2026)
  8. 7.4.2 Global Nimodipine Injection Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Nimodipine Injection Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Nimodipine Injection Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Nimodipine Injection Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Nimodipine Injection Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Nimodipine Injection Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Nimodipine Injection Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Nimodipine Injection Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Nimodipine Injection Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Nimodipine Injection Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Nimodipine Injection Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Nimodipine Injection Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Nimodipine Injection Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Nimodipine Injection Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Nimodipine Injection Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Nimodipine Injection Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Nimodipine Injection Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Nimodipine Injection Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Nimodipine Injection Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Nimodipine Injection Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Nimodipine Injection Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Nimodipine Injection Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Nimodipine Injection Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Nimodipine Injection Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Nimodipine Injection Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Nimodipine Injection Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Nimodipine Injection Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Nimodipine Injection Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Nimodipine Injection Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Nimodipine Injection Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Nimodipine Injection Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Nimodipine Injection Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Nimodipine Injection Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Nimodipine Injection Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Nimodipine Injection Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Nimodipine Injection Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Nimodipine Injection Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Nimodipine Injection Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Nimodipine Injection Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Nimodipine Injection Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Nimodipine Injection Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Nimodipine Injection Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Nimodipine Injection Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Nimodipine Injection Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Nimodipine Injection Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Nimodipine Injection Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Nimodipine Injection Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Nimodipine Injection Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Nimodipine Injection Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Nimodipine Injection Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Nimodipine Injection Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Nimodipine Injection Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Nimodipine Injection Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Nimodipine Injection Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Nimodipine Injection Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Nimodipine Injection Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Nimodipine Injection Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Nimodipine Injection Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Nimodipine Injection Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Nimodipine Injection Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Nimodipine Injection Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Nimodipine Injection Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Nimodipine Injection Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Nimodipine Injection Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Nimodipine Injection Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Nimodipine Injection Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Nimodipine Injection Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Nimodipine Injection Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Nimodipine Injection Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Nimodipine Injection Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Nimodipine Injection Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Nimodipine Injection Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Nimodipine Injection Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Nimodipine Injection Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Nimodipine Injection Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Nimodipine Injection Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Nimodipine Injection Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Nimodipine Injection Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Nimodipine Injection Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Nimodipine Injection Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Nimodipine Injection Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Nimodipine Injection Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Nimodipine Injection Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Nimodipine Injection Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Nimodipine Injection Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Huiyu Pharmaceutical
  2. 8.1.1 Huiyu Pharmaceutical Company Information
  3. 8.1.2 Huiyu Pharmaceutical Business Overview
  4. 8.1.3 Huiyu Pharmaceutical Nimodipine Injection Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Huiyu Pharmaceutical Nimodipine Injection Product Portfolio
  6. 8.1.5 Huiyu Pharmaceutical Recent Developments
  7. 8.2 Bayer
  8. 8.2.1 Bayer Company Information
  9. 8.2.2 Bayer Business Overview
  10. 8.2.3 Bayer Nimodipine Injection Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Bayer Nimodipine Injection Product Portfolio
  12. 8.2.5 Bayer Recent Developments
  13. 8.3 Lexicare Pharma
  14. 8.3.1 Lexicare Pharma Company Information
  15. 8.3.2 Lexicare Pharma Business Overview
  16. 8.3.3 Lexicare Pharma Nimodipine Injection Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Lexicare Pharma Nimodipine Injection Product Portfolio
  18. 8.3.5 Lexicare Pharma Recent Developments
  19. 8.4 Cisen Pharmaceutical
  20. 8.4.1 Cisen Pharmaceutical Company Information
  21. 8.4.2 Cisen Pharmaceutical Business Overview
  22. 8.4.3 Cisen Pharmaceutical Nimodipine Injection Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Cisen Pharmaceutical Nimodipine Injection Product Portfolio
  24. 8.4.5 Cisen Pharmaceutical Recent Developments
  25. 8.5 Actiza Pharmaceutical
  26. 8.5.1 Actiza Pharmaceutical Company Information
  27. 8.5.2 Actiza Pharmaceutical Business Overview
  28. 8.5.3 Actiza Pharmaceutical Nimodipine Injection Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Actiza Pharmaceutical Nimodipine Injection Product Portfolio
  30. 8.5.5 Actiza Pharmaceutical Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Nimodipine Injection Value Chain Analysis
  2. 9.1.1 Nimodipine Injection Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Nimodipine Injection Sales Mode & Process
  6. 9.2 Nimodipine Injection Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Nimodipine Injection Distributors
  9. 9.2.3 Nimodipine Injection Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst